CB
ALXN

Commerce Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Commerce Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,853
Closed -$892K – 1206
2021
Q2 		$892K Buy
4,853
+20
+0.4% +$3.43K 0.01% 648
2021
Q1 		$739K Buy
4,833
+14
+0.3% +$2.17K 0.01% 687
2020
Q4 		$753K Sell
4,819
-545
-10% -$70K 0.01% 647
2020
Q3 		$613K Sell
5,364
-286
-5% -$30.9K 0.01% 633
2020
Q2 		$634K Buy
5,650
+1,439
+34% +$153K 0.01% 599
2020
Q1 		$378K Buy
4,211
+706
+20% +$69.3K ﹤0.01% 681
2019
Q4 		$379K Buy
3,505
+21
+0.6% +$2.25K ﹤0.01% 741
2019
Q3 		$341K Buy
3,484
+117
+3% +$13.2K ﹤0.01% 736
2019
Q2 		$441K Buy
3,367
+746
+28% +$96.1K ﹤0.01% 643
2019
Q1 		$355K Sell
2,621
-927
-26% -$115K ﹤0.01% 669
2018
Q4 		$345K Buy
3,548
+1,248
+54% +$148K ﹤0.01% 646
2018
Q3 		$320K Buy
2,300
+548
+31% +$68.7K ﹤0.01% 718
2018
Q2 		$218K Buy
+1,752
New +$205K ﹤0.01% 815
2016
Q1 		– Sell
-1,169
Closed -$223K – 814
2015
Q4 		$223K Sell
1,169
-260
-18% -$45.4K ﹤0.01% 731
2015
Q3 		$223K Buy
+1,429
New +$261K ﹤0.01% 732
2013
Q3 		– Sell
-2,452
Closed -$226K – 787
2013
Q2 		$226K Buy
+2,452
New +$236K ﹤0.01% 686

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Commerce Bank's ALXN Position: Q3 2021 in Review

Commerce Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,853 shares — an estimated $892K sold.

Commerce Bank first reported a position in ALXN in Q2 2013 and held it in 16 quarters. The position peaked at $892K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Commerce Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Commerce Bank sold 4,853 Alexion Pharmaceuticals shares in Q3 2021, an estimated $892K.
  • Commerce Bank first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Commerce Bank's Alexion Pharmaceuticals position peaked at $892K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Commerce Bank's 13F filing for Q3 2021, filed 9 Nov 2021.